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Objectives The purpose of this study was to evaluate the mechanisms for improved exercise capacity after endurance exer-
cise training (ET) in elderly patients with heart failure and preserved ejection fraction (HFPEF).
Background Exercise intolerance, measured objectively by reduced peak oxygen consumption (VO2), is the primary chronic
symptom in HFPEF and is improved by ET. However, the mechanisms are unknown.
Methods Forty stable, compensated HFPEF outpatients (mean age 69  6 years) were examined at baseline and after
4 months of ET (n  22) or attention control (n  18). The VO2 and its determinants were assessed during rest
and peak upright cycle exercise.
Results After ET, peak VO2 in those patients was higher than in control patients (16.3  2.6 ml/kg/min vs. 13.1 
3.4 ml/kg/min; p  0.002). That was associated with higher peak heart rate (139  16 beats/min vs. 131  20
beats/min; p  0.03), but no difference in peak end-diastolic volume (77  18 ml vs. 77  17 ml; p  0.51), stroke
volume (48  9 ml vs. 46  9 ml; p  0.83), or cardiac output (6.6  1.3 l/min vs. 5.9  1.5 l/min; p  0.32). How-
ever, estimated peak arterial-venous oxygen difference was significantly higher in ET patients (19.8  4.0 ml/dl vs.
17.3  3.7 ml/dl; p  0.03). The effect of ET on cardiac output was responsible for only 16% of the improvement in
peak VO2.
Conclusions In elderly stable compensated HFPEF patients, peak arterial-venous oxygen difference was higher after ET and
was the primary contributor to improved peak VO2. This finding suggests that peripheral mechanisms (improved
microvascular and/or skeletal muscle function) contribute to the improved exercise capacity after ET in HFPEF.
(Prospective Aerobic Reconditioning Intervention Study [PARIS]; NCT01113840) (J Am Coll Cardiol 2012;60:
120–8) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.02.055Approximately 50% or more of heart failure (HF) patients
living in the community have HF with preserved left
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2012, accepted February 6, 2012.ventricular ejection fraction (HFPEF), and the proportion is
higher among women and the very elderly (1,2). As in
patients with HF and reduced EF (HFREF), the primary
chronic symptoms in HFPEF, even when well compen-
sated, are those of severe exercise intolerance (3–8)—
dyspnea on exertion and exertional fatigue—and reduced
quality of life (4). However, the pathophysiology of exercise
intolerance in this large and growing group of patients is not
well understood, and there are relatively few data regarding
its treatment (9).
See page 129
Exercise intolerance can be objectively measured as re-
duced peak exercise oxygen consumption (VO2) by expired
as analysis, a technique that is valid and reproducible,
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July 10, 2012:120–8 Mechanisms of Exercise Training in HFPEFincluding in elderly patients with HFPEF (10,11). In
accordance with the Fick equation, reduced peak VO2
results from either reduced cardiac output (CO), peripheral
arterial-venous oxygen difference (A-VO2 Diff), or both.
esults from several cross-sectional studies have suggested
hat decreased peak VO2 in elderly HFPEF patients is due
to reduced peak CO secondary to blunted chronotropic,
inotropic, and vasodilator reserve (6,7), whereas others have
suggested that it is due to reductions in both peak CO and
A-VO2 Diff (3,12,13) or primarily due to reduced peak
A-VO2 Diff secondary to impaired skeletal muscle oxidative
etabolism (14).
Many studies have reported that endurance exercise
raining improves peak VO2 in patients with HFREF
15–18), and that this improvement results from favorable
hanges in cardiac (15,19–21), peripheral vascular (19), and
keletal muscle function (20,22–24), that increase oxygen
elivery to and utilization by the active muscles (i.e.,
ncreased A-VO2 Diff). In contrast, there have been only 4
tudies of exercise training in patients with HFPEF (25–28).
n our recent report of the first randomized, controlled,
ingle-blind trial of exercise training in elderly patients with
FPEF (26), we found that 4 months of endurance exercise
raining significantly increased peak VO2, and this was recently
onfirmed in a multicenter trial (28). However, the mecha-
isms responsible for the improvement in peak VO2 with
xercise training in HFPEF have not been examined. That can
e challenging as it requires simultaneous measurement of
O2 and its determinants during peak exercise (29). Thus,
the aim of this study was to evaluate the acute cardiovascular
and metabolic responses during upright cycle exercise before
and after 4 months of endurance exercise training in elderly
patients with chronic HFPEF. Our goal was to determine
the mechanisms of the improvement in peak VO2 after
exercise training, and particularly the relative contribu-
tions of the components of the Fick equation, CO, and
A-VO2 Diff.
ethods
tudy design and subjects. The study design, subjects, and
nclusion criteria have previously been described (4,26).
riefly, HFPEF patients were recruited by review of clinic
isits and hospital discharge records from Wake Forest
edical Center. The subjects in this report are a subset of
hose from our recently reported randomized, single-blind
rial of exercise training (26) who had adequate acoustic
indows for the evaluation of left ventricular (LV) volumes
uring upright rest and cycle exercise by 2-dimensional
chocardiographic imaging. At baseline, subjects performed
cardiopulmonary exercise test with 2-dimensional echo-
ardiography and were then randomly assigned to either 4
onths of endurance exercise training or attention control.
ardiopulmonary exercise testing protocol. Exercise test-
ng was performed as previously described in the upright
osition on an electrically braked cycle ergometer with expiredas analysis (CPX-2000, Med-
raphics, Minneapolis, Minne-
ota) (4,26). The initial power
utput was set at 12.5 W for 2
in, increased to 25 W for 3
in, followed thereafter by 25 W
ncrements every 3 min until vo-
itional exhaustion. Peak VO2
was calculated as the highest ox-
ygen consumed over the last 30 s
of peak exercise (4,26).
Rest and exercise echocardio-
graphy. Resting and exercise
echocardiograms were performed
as previously described (4,13,26) by
an experienced, registered echo-
sonographer using a Philips Sonos
5500 (Andover, Massachusetts) ultrasound imaging system
fitted with multifrequency transducer. Standard 2-dimensional
images were obtained in the parasternal long-axis and short-
axis views and apical 4- and 2-chamber views. During exercise,
the sonographer focused on capture of optimal apical
4-chamber views for LV volume assessment (13). Left
ventricular end-diastolic and end-systolic volumes were
calculated using the single plane ellipsoid apical 4-chamber
area-length method (30,31) by a second experienced echo-
sonographer who did not participate in image acquisition
and who was blinded to the subject’s randomization group
allocation (31). Adequate images for evaluation of LV
volumes were defined as a well-aligned LV without apical
foreshortening and with the ventricular endocardial con-
tours well visualized for tracing (30,32). All results were
averaged from 3 single-beat digital cineloops (4,13). We have
previously validated 2-dimensional echocardiographic volume
measurements of end-diastolic volume against end-diastolic
volume derived from radionuclide angiography (Fick stroke
volume divided by radionuclide angiography ejection frac-
tion) in elderly persons and reported excellent day-to-day
reproducibility and intraobserver and interobserver variabil-
ity (13).
Continuous heart rate and noninvasive blood pressure
(cuff sphygmomanometer) were acquired at rest and exer-
cise. Stroke volume, CO, and systemic vascular resistance
were derived from standard equations (13). The A-VO2
Diff was calculated by using the Fick equation (VO2 divided
by CO) (13). Circulatory power was calculated as VO2
times systolic blood pressure (33).
Endurance exercise training. As previously described, med-
ically supervised endurance exercise training was performed
3 days a week for 4 months, during which time the exercise
intensity progressively increased from 40% to 70% heart rate
reserve (26). Exercise training sessions consisted of walking
on a track and cycling on a Schwinn Airdyne (Louisville,
Colorado) for up to as much as 60 min per session including
Abbreviations
and Acronyms
ANCOVA  analysis of
covariance
A-VO2 Diff  arterial-venous
oxygen difference
CO  cardiac output
HF  heart failure
HFPEF  heart failure and
preserved ejection fraction
HFREF  heart failure and
reduced ejection fraction
LV  left ventricular
VO2  exercise oxygen
consumptionwarm up and cool down. Any missed sessions were made up
w
c
e
v
t
n
S
i
r
a
d
d
e
(
o
c
e
B
v
d
t
i
a
M
A
M
T
m
e
N
122 Haykowsky et al. JACC Vol. 60, No. 2, 2012
Mechanisms of Exercise Training in HFPEF July 10, 2012:120–8so all subjects completed a minimum of 40 of 48 training
sessions (26).
Attention control group. The attention control subjects
ere contacted every 2 weeks, during which time the
onversations focused on study retention, reminders, and
ncouragement regarding attendance of upcoming study
isits, and collection information on any new medical events
hey experienced since prior contact (26). The subjects were
ot provided with information regarding exercise.
tatistical analysis. Comparison of the baseline character-
stics of the attention control and endurance exercise trained
andomized groups were made by showing the mean SD,
nd were tested using the 2-sample t test for continuous
ata and percentages and tested using Fisher’s exact test for
ichotomous data or the chi-square test for categorical data.
Testing for the statistical significance of the effect of the
xercise training was performed by analysis of covariance
ANCOVA) using the 4-month follow-up value of each
utcome with the baseline measure of that outcome as a
ovariate. The assumption of normality of the residuals and
qual variances for the ANCOVA model were checked.
ecause peak VO2 was positively skewed, analyses of this
ariable were based on logarithmic transformation. A me-
iation analysis was performed to estimate the effect of exercise
raining on peak CO and its relative contribution to the change
n peak VO2 after exercise training (34). The mediation
nalysis consisted of fitting 3 ANCOVA models as follows:
odel 1. VO2  a1  b1BVO2  c1EX, where BVO2 is
baseline peak VO2 and EX is an indicator indicating being
assigned to the exercise training group. The coefficient c1
estimates the overall (or total) effect on peak VO2 of
randomization to the exercise group.
Model 2. Mediator  a2  b2BVO2  c2EX  d2VO2. If
EX does not have an independent effect on the mediator,
then the variable cannot be a significant mediator for VO2.
ssuming it is, then:
odel 3. VO2  a3  b3BVO2  c3EX  d4Mediator.
he coefficient c3 is an estimate of the independent effect of
EX on peak VO2 not accounted for by the effect of EX on
the mediator and its association with peak VO2. The
mediation effect is estimated by c1 minus c3. The percent of
the effect EX had on peak VO2 that was explained by the
ediator is expressed as: (1  c3/c1)  100%. Goodman’s
unbiased estimated of the standard error was used (34).
All statistical tests were performed at the 5% 2-sided level
of significance.
Results
Baseline characteristics. As previously reported (26), a
total of 46 participants completed the 4-month study (24
randomized to endurance exercise training and 22 random-
ized to attention control). Among these, there were 40
subjects (22 endurance exercise trained and 18 attention
control) who had adequate rest and exercise echocardio-
graphic images for the determination of LV volumes duringrest and exercise, and these subjects are the focus of the
present report. There were no significant baseline differ-
ences in key demographic or clinical characteristics between
the 2 treatment groups (Table 1). Further, there were no
significant differences in any key variables in the subset of
subjects in this report compared to the larger trial including
age (69 years vs. 71 years, p  0.24); body mass index (30.4
vs. 30.4, p  0.93), weight (79.4 kg vs. 79.2 kg, p  0.97),
and percent female (88% vs. 85%, p  1.0).
Effects of endurance training on variables obtained at rest.
There were no significant differences between groups after
the 4-month intervention in resting heart rate, end-diastolic
volume, end-systolic volume, stroke volume, CO, systolic,
diastolic, or mean arterial blood pressures, systemic vascular
resistance, or estimate A-VO2 Diff (Tables 2 and 3).
Effects of endurance training on peak exercise variables.
Peak VO2 was significantly higher after 4 months of endurance
xercise training compared to attention control (16.3  2.6
ml/kg/min vs. 13.1  3.4 ml/kg/min) (Table 2). The change
in peak VO2 and heart rate for the subjects in this study
(2.3 ml/kg/min and 6 beats/min, respectively) was
similar to that previously reported for the entire cohort of
endurance exercise trained subjects (26). The respiratory
exchange ratio was similar between groups (1.15  0.09 vs.
1.13  0.11; p 0.18), and in both was 1.10, indicating
an exhaustive level of effort. Peak and reserve (peak exercise
minus rest) heart rate were significantly higher after 4
Patient CharacteristicsTable 1 Patient Characteristics
Characteristic Exercise (n  22) Control (n  18) p Value
Age, yrs 70 6 68 5 0.43
Women 18 (82) 17 (94) 0.36
Caucasian 20 (91) 14 (78) 0.38
Body weight, kg 79 17 79 17 0.94
BSA, m2 1.85 0.21 1.80 0.18 0.44
BMI, kg/m2 29.6 5.7 31.3 7.1 0.40
NYHA functional class
II 14 (64) 12 (67) 1.0
III 8 (36) 6 (33) 1.0
Diastolic function
Normal 5 (25) 3 (17) 0.70
Abnormal relaxation 13 (65) 11 (61) 1.0
Pseudonormal 2 (10) 4 (22) 0.39
History of pulmonary edema 2 (9) 5 (28) 0.21
Diabetes mellitus 2 (9) 4 (22) 0.38
History of hypertension 18 (82) 13 (72) 0.71
Current medication
ACE inhibitors 7 (32) 3 (17) 0.46
Digoxin 4 (18) 3 (17) 1.0
Diuretics 12 (55) 11 (61) 1.0
Beta-blockers 7 (32) 3 (17) 0.46
Calcium antagonists 10 (45) 8 (44) 1.0
Nitrates 2 (9) 0 (0) 0.49
Values are mean  SD or count (%).
ACE  angiotensin-converting enzyme; BMI  body mass index; BSA  body surface area;
YHA  New York Heart Association.months of endurance training compared to attention con-
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July 10, 2012:120–8 Mechanisms of Exercise Training in HFPEFtrols (139  16 beats/min vs. 131  20 beats/min, p 
0.03; and 69  17 beats/min vs. 57  17 beats/min, p 
0.01, respectively).
After 4 months of endurance training, there were no
significant differences between groups for peak exercise LV
end-diastolic volume (77  18 ml vs. 77  17 ml, p  0.51),
end-systolic volume (30 11 ml vs. 31 13 ml, p 0.58),
stroke volume (48  9 ml vs. 46  9 ml, p  0.83), CO
(6.6  1.3 l/min vs. 5.9  1.5 l/min, p  0.32), systolic
(187  22 mm Hg vs. 178  28 mm Hg, p  0.19),
diastolic (89  10 mm Hg vs. 84  8 mm Hg, p  0.43)
or mean arterial pressures (122  12 mm Hg vs. 116  14
mm Hg, p 0.22), or systemic vascular resistance (1,499
303 dyns/s/cm5 vs. 1631  440 dyns/s/cm5, p  0.32
Rest and Peak Exercise Oxygen Consumption and its DeterminantTable 2 Rest and Peak Exercise Oxygen Consumption and its
Rest
Variable Group Baseline Follow-Up p Value
VO2, ml/min CON 261 51 256 59 0.68
EX 289 100 271 55
VO2, ml/kg/min CON 3.4 0.7 3.4 0.9 0.96
EX 3.8 1.4 3.5 0.8
Heart rate, beats/min CON 77 13 74 13 0.62
EX 75 17 71 16
End-diastolic volume, ml CON 70 22 70 22 0.41
EX 71 22 72 20
End-systolic volume, ml CON 31 14 31 15 0.61
EX 30 12 30 11
Stroke volume, ml CON 39 11 39 10 0.059
EX 41 12 43 10
Cardiac output, l/min CON 3.1 0.7 2.8 0.7 0.24
EX 3.1 1.0 3.0 0.8
Circulatory power,
ml/kg/min·mm Hg
CON
EX
492 133
546 172
478 180
484 102
0.65
A-VO2 Diff, ml/dl CON 8.6 2.0 9.2 2.3 0.99
EX 9.7 2.7 9.8 2.7
Values are mean  SD. The p value represents comparison between the groups of the follow-up l
A-VO2 Diff  arterial-venous oxygen difference; CON  attention control; EX endurance exerc
Rest and Peak Exercise Hemodynamics at Baseline and After ExerTable 3 Rest and Peak Exercise Hemodynamics at Baseline an
Hemodynamics
Variable Group Baseline
Systolic blood pressure, mm Hg CON 146 22
EX 147 20
Diastolic blood pressure, mm Hg CON 80 9
EX 82 7
Mean arterial pressure, mm Hg CON 102 12
EX 104 9
Systemic vascular resistance, dyn·s/cm5 CON 2,824 941
EX 2,973 1,009
Pulse pressure, mm Hg CON 66 17
EX 65 18
Pulse pressure/stroke volume, mm Hg/ml CON 1.83 0.77
EX 1.68 0.57Values are mean  SD. The p value represents comparison of least-square means at final visit after adju
Abbreviations as in Table 1.(Tables 2 and 3, Fig. 1). The percent reduction in systemic
vascular resistance from rest to peak exercise in exercise
group compared to controls was also unchanged after
training (44  13% vs. 45  14%, p  0.46). However,
stimated peak and reserve A-VO2 Diff were significantly
reater after endurance exercise training compared to atten-
ion controls (19.8  4.0 ml/dl vs. 17.3  3.7 ml/dl, p 
.03; and 10.5  4.2 ml/dl vs. 7.2  3.3 ml/dl, p  0.01)
Table 2, Fig. 1). Finally, peak and reserve circulatory power
ere significantly greater after endurance training (Table 2).
elative contributions of CO and A-VO2Diff to the
improvement in peak exercise VO2 after endurance training.
We performed a mediation analysis to: 1) estimate the effect
of endurance exercise training on peak exercise VO2;
seline and Follow-Up After Exercise Trainingminant at Baseline and Follow-Up After Exercise Training
Peak Exercise Reserve (Peak–Rest)
eline Follow-Up p Value Baseline Follow-Up p Value
 211 997 255 0.003 735 207 734 230 0.001
 250 1,285 313 806 226 1,014 286
 2.7 13.1 3.4 0.002 9.4 2.6 9.5 3.0 0.001
 2.5 16.3 2.6 10.3 2.3 12.8 2.4
 22 131 20 0.03 56 17 57 17 0.01
 21 139 16 59 19 69 17
 22 77 17 0.51 6 7 8 9 0.20
 25 77 18 9 9 5 9
 16 31 13 0.58 0 5 0 4 0.98
 13 30 11 0 5 0 6
 10 46 9 0.83 6 5 8 7 0.09
 13 48 9 8 8 5 5
 1.4 5.9 1.5 0.32 3.1 0.9 3.4 1.1 0.56
 2.0 6.6 1.3 3.4 1.6 3.8 1.0
 525
 643
2,295 687
3,080 712
0.002 1,846 523
2,084 592
1,817 608
2,596 670
0.001
 3.9 17.3 3.7 0.03 8.2 3.0 7.2 3.3 0.01
 4.4 19.8 4.0 8.3 4.2 10.5 4.2
uare means after adjustment for baseline.
ing; Grp  group assignment; VO2  exercise oxygen consumption.
Traininger Exercise Training
st Peak Exercise
llow-Up p Value Baseline Follow-Up p Value
40 21 0.49 184 25 178 28 0.19
38 16 186 29 187 22
78 9 0.89 84 9 84 8 0.43
80 10 88 9 89 10
99 13 0.77 117 14 116 14 0.22
99 10 121 13 122 12
29 654 0.24 1,632 374 1,631 440 0.32
84 753 1,569 417 1,499 303
62 15 0.28 99 19 94 24 0.26
58 12 97 25 99 19
72 0.56 0.053 2.32 0.78 2.11 0.56 0.41
42 0.42 2.08 0.68 2.07 0.55at BaDeter
Bas
998
1095
12.9
14.0
133
133
76
79
31
30
45
49
5.9
6.5
2,337
2,609
17.4
17.7cised Aft
Re
Fo
1
1
2,9
2,7
1.
1.stment for baseline values.
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Mechanisms of Exercise Training in HFPEF July 10, 2012:120–82) estimate the contribution of CO to the increase in peak
exercise VO2 resulting from endurance training; and
) estimate the contribution of factors other than CO to the
ncrease in peak VO2 from endurance training. Based on
ANCOVA, endurance training increased peak VO2 by
19.8% compared to attention control. Considering CO as a
mediator of the effect of training on peak VO2, a model
estimating the effect on peak VO2 while controlling for CO
indicated that the magnitude of the effect of training on
peak VO2 that was explained by its effect on CO was 3.2%
or in relative terms 3.2/19.8 16% of the total improvement
n peak VO2). Thus, 84% (16.6/19.8  84%) of the training-
elated improvement in peak VO2 was due to factors other
han cardiac output (i.e., improved A-VO2 Diff).
iscussion
n the growing population of elderly persons, HFPEF is the
ost common form of HF (1,2). Exercise intolerance is the
rimary manifestation in outpatients with chronic HFPEF
ven when patients are stable and compensated; however, its
athophysiology and treatment are not well understood (9).
his study evaluated the effect of 4 months of endurance
Figure 1 Peak Exercise Data at Baseline and 4-Month Follow-U
Peak exercise data at baseline and 4-month follow-up for (A) heart rate, (B) st
Solid circles and solid lines represent the group randomly assigned to exercis
the attention control group. Values displayed at each time point are raw mean
comparison of least-square means at follow-up after adjustment for baseline vxercise training on cardiovascular and metabolic responses io acute cycle exercise in older HFPEF patients. The main
ew finding of this study was that increased peak exercise
-VO2 Diff estimated from the Fick equation was the
rimary contributor to the increase in peak VO2 that
resulted from endurance exercise training, whereas peak
exercise stroke volume and CO were not significantly
changed (Table 2, Fig. 1). These findings provide potential
insight into the pathophysiology of exercise intolerance in
HFPEF and the design of future treatments specifically
focused on addressing it.
Although there have been many reports of the effect of
exercise training in patients with HFREF (18,35–38),
nearly all of which have shown substantial improvements in
exercise capacity, to date there have been only 4 reported
studies of exercise training in patients with HFPEF (25–28). A
critical question in such studies is the mechanisms underlying
the training-related improvement in exercise capacity. How-
ever, this requires measurement of VO2 and its determinants
uring peak exercise, which can be challenging in humans
9,29). As a result, a relatively small number of the training
tudies in HFREF patients have been able to examine this
uestion (15–17,19,21,22,39,40), and ours is the first to do so
olume, (C) cardiac output, and (D) arterial-venous oxygen (A-VO2) difference.
ing; open squares and dashed line represent patients randomly allocated to
. *p  0.03. All p values are from the analysis of covariance model based onp
roke v
e train
 SE
alues.n elderly patients with stable compensated HFPEF.
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July 10, 2012:120–8 Mechanisms of Exercise Training in HFPEFGiven that there are no comparable data on the determi-
nants of the training-related improvement in exercise ca-
pacity in HFPEF, a review of data in HFREF patients is
instructive. In HFREF patients, Hambrecht et al. (19,22)
reported that 6 months of endurance exercise training
increased peak exercise heart rate and CO. In contrast,
Sullivan et al. (16) and others (17,39,40) reported no
significant change in peak stroke volume and CO after
endurance exercise training in HFREF patients, and that
increased peak A-VO2 Diff measured invasively by direct
oximetry was the major contributor to improved exercise
capacity. Dubach et al. (21) found that 2 months of
high-intensity endurance training improved both peak ex-
ercise CO and A-VO2 Diff in HFREF patients. Taken
ogether, studies performed in HFREF patients suggest
hat the increased peak VO2 after 2 to 6 months of
ndurance exercise training is due to increased peak CO
nd/or A-VO2 Diff. When present, increased peak CO was
ue primarily to increased peak heart rate as peak stroke
olume was not significantly increased after training in any
f these studies in HFREF patients (16,17,19–21,40,41).
These prior investigations in patients with HFREF
lready discussed (16,17,39) and others involving healthy
ubjects (42–44), including several that measured peak
-VO2 Diff by direct oximetry, support the plausibility of
ur results indicating that the improvement in peak exercise
O2 in elderly HFPEF patients after 4 months of endur-
nce training was due primarily to an increased peak A-VO2
Diff. Of note, this is contrary to our a priori hypothesis
during the design of the trial. We had hypothesized, on the
basis of our earlier report in a small number of patients (3),
that increased peak LV stroke volume and cardiac output
would be the primary contributors to an endurance training
related increase in peak VO2. However, our recently pub-
lished cross-sectional analysis of the baseline exercise test
results indicated that the strongest determinant of the
severely reduced exercise capacity in HFPEF patients com-
pared to age-matched, healthy control subjects was reduced
peak A-VO2 Diff (13). It is noteworthy that even in our
arly cross-sectional comparison study, an unheralded find-
ng was that A-VO2 Diff, measured invasively by direct
oximetry, was impaired during exercise in HFPEF patients
(3), an observation recently confirmed by Bhella et al. (14).
Thus, 3 published studies from 3 separate laboratories, using
3 different techniques, have shown that at baseline before
exercise training, HFPEF patients have reduced peak exer-
cise A-VO2 Diff and this contributes to their reduced peak
O2. To measure peak A-VO2 Diff, 1 used direct oximetry,
used the Fick technique with acetylene rebreathing mea-
urements of cardiac output, and 1 used the Fick technique
ith cardiac output measured by 2-dimensional echocardi-
graphy volumes (3,13,14).
The finding of increased peak A-VO2 Diff indicates that
after exercise training there was an improvement in either
diffusive oxygen transport by improved peripheral vascular,
microvascular function and/or increased oxygen utilizationby the active muscles. The available data do not allow us to
discern which of these was operational in the present study.
In HFREF patients, peripheral arterial dilation is impaired
and improves after exercise training (45). However, we have
previously reported that resting and flow-mediated increases
in leg blood flow in elderly HFPEF patients are not
significantly impaired and are similar to those of age-
matched healthy subjects (5). We and others have shown in
cross-sectional analyses that arterial stiffness is markedly
increased in HFPEF patients and is related to their reduced
exercise capacity (6,46,47). In the present study, we did not
perform formal measurements of arterial stiffness at rest or
during exercise. However, after exercise training peak and
the percent change in systemic vascular resistance were
unchanged and the ratio of pulse pressure to stroke volume,
a crude measure of arterial stiffness, although borderline
reduced at rest (p  0.053) (Table 3), was not different at
peak exercise. This finding suggests that the increase in peak
A-VO2 Diff may be due to improved microvascular function
nd/or skeletal muscle adaptations that results in increased
xygen utilization by the active muscles.
The suggestion that improved skeletal muscle adaptations
ay have contributed to the training-related improvement
n peak VO2 is supported by a variety of other data. Several
cross-sectional studies have shown that HFREF patients
and healthy elderly subjects have alterations in skeletal
muscle bulk, composition, and function that correlate with
their reduced exercise capacity (48–51). Bhella et al. (14)
also recently reported that elderly HFPEF patients have
impaired skeletal muscle oxidative metabolism. Studies
involving a wide variety of animal models and human
subjects indicate that skeletal muscle has a large capacity for
favorable remodeling induced by exercise. Most relevant to
elderly HFPEF patients are several studies of HFREF
patients and of healthy elderly subjects that have demonstrated
that exercise training produces a variety of favorable skeletal
muscle adaptations, including increased percent oxidative fibers
(22), oxidative enzyme activity (20,22–24,50), and capillary
density (23). Further studies will be required to determine
the specific vascular and/or skeletal muscle mechanisms
underlying the finding in the present study of a training-
mediated increase in peak A-VO2 Diff in HFPEF patients.
The results of prior mechanistic studies of endurance
training in patients with HFREF (16,17) and in healthy
elderly subjects (42,44) also support the plausibility of our
results, indicating that endurance exercise training did not
significantly enhance peak exercise left ventricular end-
diastolic volume, end-systolic volume, or stroke volume in
elderly HFPEF patients. As seen in patients with HFREF
(22,41), we found that training did increase peak heart rate,
representing a possible mitigation of the chronotropic in-
competence that was described by our group (3,29,52) and
subsequently confirmed by others (6,7) in patients with
HFPEF. However, the increased peak exercise heart rate
did not translate into a significant training-related increase
in peak exercise CO.
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with endurance exercise training may be related to sex-
related differences in the effect of endurance exercise train-
ing on cardiac function. Specifically, Spina et al. (42,43)
reported that the increase in peak VO2 after endurance
training in healthy elderly men was primarily due to an
augmented peak stroke volume and CO and to a lesser
extent to increased A-VO2 Diff. In contrast, the increased
eak VO2 in healthy elderly women was due entirely to an
ncrease in peak A-VO2 Diff as peak exercise stroke volume,
eart rate, and CO were unchanged after training (42,43).
f note, nearly all of the HFREF patients in prior mech-
nistic exercise trials were men (18), whereas the majority of
atients in the present study of HFPEF were women,
eflecting the sex distribution of HFPEF in the general
opulation (2).
The intensity of the prescribed training program can also
mpact rest and exercise cardiovascular function. Wisloff et
l. (53) reported that high-intensity interval aerobic training
as superior to continuous moderate intensity endurance
xercise training for improving resting ejection fraction,
eripheral vascular function, and skeletal muscle mitochon-
rial biogenesis in elderly men with HRFEF. Nechwatal et
l. (40) found that short-term high-intensity aerobic inter-
al training significantly increased peak exercise stroke
olume and CO and reduced systemic vascular resistance
ut there was no change in these outcomes after moderate
ntensity continuous endurance training in patients with
FREF. Thus, we cannot exclude the possibility that
igh-intensity aerobic interval training could result in sig-
ificant improvements in peak exercise cardiac function in
FPEF.
The type of exercise training can also impact results. Our
tudy utilized endurance training only. However, resistance
raining has been shown to significantly increase skeletal
uscle mass and strength as well as improve aerobic
apacity specifically in elderly men and elderly women
54,55). Our observations regarding the contribution of
eripheral mechanisms to the training-related improve-
ents in exercise capacity suggest that this modality should
e specifically examined in future training studies of elderly
FPEF patients.
Cohen-Solal et al. (33) previously reported that peak
xercise circulatory power was the single best predictor of
urvival in HFREF patients. Specifically, over a 25-month
ollow-up period, HFREF patients with a peak circulatory
ower 3,047 mm Hg had significantly greater event-free
urvival compared to HFREF patients whose circulatory
ower was below this value. Our finding that 16 weeks of
ndurance training increased peak circulatory power above
his threshold value may have important prognostic impli-
ations for elderly HFPEF patients.
tudy limitations. Two-dimensional echocardiography
an systematically underestimate LV volumes, so our rest
nd peak exercise CO values may have been underestimated
30,31,56). However, our baseline peak CO values areimilar to that reported by Ennezat et al. (8) in older
FPEF patients during cycle exercise at a similar peak
ower output to our subjects, although they are slightly
ower than the peak exercise values reported by Borlaug et al. (6)
n HFPEF patients.
The A-VO2 Diff was not measured by direct oximetry.
Although desirable, this would have involved invasive cath-
eterization of pulmonary and systemic arteries during ex-
haustive upright exercise at baseline and again at follow-up
of elderly outpatients and would have involved significant
participant burden and risk. Instead, A-VO2 Diff was
estimated using the Fick equation where VO2 measured by
xpired gas analysis is divided by measured CO. The Fick
echnique has been used to calculate A-VO2 Diff in a
umber of recent physiologic studies investigating mecha-
isms of exercise intolerance that have included HFPEF
atients (13,14,56–58). Our peak A-VO2 Diff values were
omewhat higher than those reported by others (14,59,60),
ossibly due to under-estimation of CO. However, the
bsolute change in peak A-VO2 Diff with exercise training
in our HFPEF patients is similar to that found after exercise
training in HFREF patients in studies in which it was
measured by direct oximetry using invasively obtained sys-
temic and pulmonary arterial blood samples (16,21). Most
importantly, because key variables were measured at all
testing times using identical methods in both groups, and
because we assessed changes in reserve capacity (rest minus
peak values) within individual subjects, comparisons of CO
and estimated A-VO2 Diff between groups are valid.
Although the Doppler indexes at supine rest in the overall
group indicated the presence of abnormal LV diastolic
filling (13), due to technical limitations including merging
of the E-wave and A-wave, these were not measured during
upright exercise. Tissue Doppler was not performed; there-
fore, changes in LV systolic and diastolic function may have
occurred that we were unable to detect. However, any
physiologically significant changes in this regard may have
been expected to impact rest and peak exercise stroke
volume, which was not changed after the 4-month training
program. Although all patients had normal mitral valve
morphology and function at rest, we cannot exclude the
possibility that exercise-induced mitral regurgitation could
have impacted peak stroke volume. Intracardiac hemody-
namics were not measured, as these require invasive tech-
niques that are challenging in studies such as ours that
require serial assessments in elderly outpatients and involve
significant human research subject risk (57).
Our patients met objective, standardized criteria for heart
failure, and had features that closely match patients with
HFPEF in other published studies, including in the char-
acteristics of diastolic filling, body mass index, and diuretic
use. Because our study involved serial, exhaustive exercise
tests and 4 months of exercise training, patients were
required to be stable and compensated with no recent
hospitalizations or medication changes. Thus, they would
be expected to have less severe symptoms and biomarker
127JACC Vol. 60, No. 2, 2012 Haykowsky et al.
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pitalization and decompensation. Nevertheless, as recently
reviewed by others (61,62), the diagnosis of HFPEF can be
difficult and that remains a limitation to this and most
HFPEF investigations.
In the mediation analysis, measurement error of cardiac
output could potentially introduce positive bias. That would
be inversely proportional to the coefficient of variation. The
reliability of cardiac output measurement in our laboratory is
90%. Thus, we believe that the potential for positive bias
is relatively modest.
Conclusions
The improvement in peak exercise capacity after 4 months
of endurance exercise training in elderly, stable, compen-
sated HFPEF patents was due primarily to increased peak
A-VO2 Diff. This finding suggests that peripheral vascular,
microvascular, and/or skeletal muscle function were im-
proved and resulted in increased diffusive oxygen transport
or greater oxygen utilization by the active skeletal muscle.
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